➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Baxter
Colorcon
Mallinckrodt
Merck

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ABALOPARATIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for ABALOPARATIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01343004 Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women Completed Radius Health, Inc. Phase 3 2011-04-01 The purpose of this study is to determine whether BA058 (abaloparatide), a parathyroid hormone-related peptide, is effective in preventing fractures in postmenopausal women with severe osteoporosis who are at risk of fractures.
NCT01657162 Twenty Four Month Extension Study of BA058-05-003 Active, not recruiting Radius Health, Inc. Phase 3 2012-10-01 The purpose of this study is to provide 24 months of standard of care data on subjects previously enrolled in study BA058-05-003.
NCT01674621 Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis Completed Nordic Bioscience A/S Phase 2 2012-08-01 To determine the clinical safety and efficacy of BA058 Transdermal in otherwise healthy postmenopausal women with osteoporosis as assessed by changes in bone mineral density (BMD) and serum markers of bone metabolism when compared to Transdermal Placebo and BA058 Injection for 6 months of treatment.
NCT01674621 Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis Completed Radius Health, Inc. Phase 2 2012-08-01 To determine the clinical safety and efficacy of BA058 Transdermal in otherwise healthy postmenopausal women with osteoporosis as assessed by changes in bone mineral density (BMD) and serum markers of bone metabolism when compared to Transdermal Placebo and BA058 Injection for 6 months of treatment.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ABALOPARATIDE

Condition Name

Condition Name for ABALOPARATIDE
Intervention Trials
Osteoporosis 5
Osteoporosis, Postmenopausal 3
Postmenopausal Osteoporosis 2
Osteoporosis of Vertebrae 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ABALOPARATIDE
Intervention Trials
Osteoporosis 8
Osteoporosis, Postmenopausal 6
Leukemia, Myelomonocytic, Juvenile 1
Leukemia, Myelomonocytic, Chronic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ABALOPARATIDE

Trials by Country

Trials by Country for ABALOPARATIDE
Location Trials
United States 14
Denmark 3
Estonia 3
Poland 3
Lithuania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ABALOPARATIDE
Location Trials
Maryland 4
Georgia 3
Colorado 3
Massachusetts 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ABALOPARATIDE

Clinical Trial Phase

Clinical Trial Phase for ABALOPARATIDE
Clinical Trial Phase Trials
Phase 4 3
Phase 3 4
Phase 2 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ABALOPARATIDE
Clinical Trial Phase Trials
Not yet recruiting 7
Completed 2
Recruiting 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ABALOPARATIDE

Sponsor Name

Sponsor Name for ABALOPARATIDE
Sponsor Trials
Radius Health, Inc. 6
Hospital for Special Surgery, New York 2
University of Wisconsin, Madison 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ABALOPARATIDE
Sponsor Trials
Other 11
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Mallinckrodt
McKinsey
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.